Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label long-term follow-up of telmisartan + hydrochlorothiazide in hypertension
2005-003000-11Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of telmisartan and hydrochlorothiazide in essential hypertension (2 arms), sponsored by Boehringer Ingelheim. Started Aug 2005; status: completed.
02
Drugs
telmisartanhydrochlorothiazide
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2005-003000-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003000-11.